$XMTR

Miln James sold $369K of XMTR

Miln James (Chief Financial Officer) sold 3,892 shares of Xometry, Inc. (XMTR) at an average of $94.74 ($90.76–$98.51, $0.37M total) across 9 trades over 2026-07-01 to 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Miln James
Published Jul 6, 2026, 9:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XMTR
Neutral
high confidence
Mentioned
$XMTR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XMTRNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but the disclosure alone typically has limited impact absent accompanying fundamental news.

02

Market read

A routine insider-sale Form 4 for XMTR filed today; likely low incremental trading signal.

03

What to watch

The article does not state whether the CFO’s remaining holdings changed materially beyond the post-transaction share count, nor does it provide context on prior sales frequency or total compensation-driven selling.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed 2026-07-06 (after the sale dates 2026-07-01 to 2026-07-02).

Background

The article is an SEC Form 4 insider transaction: CFO Miln James executed open-market sales of XMTR shares under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$XMTRNeutralHigh confidence
Context

Xometry CFO Miln James sold $368,733 of XMTR shares via an open-market sale under a pre-arranged 10b5-1 plan (Form 4 filed today).

Expected impact

Low near-term impact; any reaction is likely muted and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, and the article provides no new operational, financial, or regulatory catalyst.

Market effects

No direct sector read-through; this is company-specific insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as confidence erosion, especially if paired with other negative signals (not present here).

Key entities

  • Xometry, Inc.

    Company whose shares were sold by its CFO under a 10b5-1 plan (XMTR).

  • Miln James

    Chief Financial Officer who sold 3,892 shares across nine trades.

  • Rule 10b5-1 plan

    Pre-arranged plan indicating the sales were scheduled in advance.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XMTRMedAI 8/10

Six Montgomery County companies attract more than $566 million in capital investment – WTOP News

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

$XMTRHighAI 9/10

Xometry (XMTR) Q2 2026 Earnings Call Transcript

Xometry (XMTR) reported Q2 2026 revenue of $229.3 million, up 41% year over year, with marketplace revenue of $215.4 million (+45%). Adjusted EBITDA was $14.1 million, and non-GAAP net income was $9.9 million. The company raised Q3 2026 revenue guidance to $234 million to $236 million and full-year 2026 revenue growth to 33% to 34%.

$XMTRMed

Xometry, Inc. Q2 2026 Earnings Call Summary

Xometry, Inc. reported Q2 2026 results and said revenue growth accelerated for a fourth straight quarter, driven by a product-led shift toward an AI ecosystem. It cited improved CNC cost prediction accuracy (+~15%), record 175 net new enterprise accounts over $50,000, and reduced ad spend to 3.4% of revenue. Full-year 2026 revenue growth guidance raised to 33%-34% and marketplace gross margin target 35%-40%. Cash was $517M after a $248M follow-on and $50M Siemens investment.

$XMTRHighAI 9/10

Xometry, Inc.: Xometry Reports Record Second Quarter 2026 Results

Xometry (NASDAQ: XMTR) reported Q2 2026 results: revenue rose 41% to $229 million, with marketplace revenue up 45% to $215 million. Gross profit increased 34% to $87.2 million and Adjusted EBITDA rose $10.2 million to $14.1 million. Cash and equivalents were $517 million after a June equity offering. Q3 guidance calls for $234-$236 million revenue and $16-$17 million Adjusted EBITDA.